|1.||Kuo, Sheng-Chu: 2 articles (05/2013 - 02/2010)|
|2.||Yang, Jai-Sing: 2 articles (05/2013 - 02/2010)|
|3.||Wen, Yen-Fang: 2 articles (05/2013 - 02/2010)|
|4.||Fushiya, Shinji: 1 article (05/2013)|
|5.||Liao, Yu-Ren: 1 article (05/2013)|
|6.||Lai, Kuang-Chi: 1 article (05/2013)|
|7.||Lu, Chi-Cheng: 1 article (05/2013)|
|8.||Wu, Tian-Shung: 1 article (05/2013)|
|9.||Wu, Hsi-Chin: 1 article (02/2010)|
|10.||Chen, Hui-Jye: 1 article (02/2010)|
02/01/2010 - "In this study, the underlying molecular mechanisms in vitro and anti-leukemia activity in vivo of ITR-284 were investigated. "
05/01/2013 - "We have previously reported that ITR-284, a potent carboxamide-derived anticancer agent, induced apoptosis in leukemia cells. "
02/01/2010 - "These results revealed that ITR-284 acted against both HL-60 and WEHI-3 in vitrovia both intrinsic and extrinsic apoptotic signaling pathways, and exhibited an anti-leukemic effect in a WEHI-3 orthotopic mice model of leukemia."
02/01/2010 - "In addition, the anti-leukemia effects of ITR-284 in vivo were further evaluated in BALB/c mice inoculated with WEHI-3 cells. "
02/01/2010 - "ITR-284 reduced the cell viability and induced apoptosis in HL-60 and WEHI-3 leukemia cells. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
05/01/2013 - "In this study, we investigated the antiproliferative effects and apoptotic induction of ITR-284 on various types of human hepatocellular and colorectal cancer cells in vitro. "
05/01/2013 - "However, there are no reports showing that ITR-284 inhibits human hepatocellular and colorectal cancer cells. "
05/01/2013 - "The novel carboxamide analog ITR-284 induces caspase-dependent apoptotic cell death in human hepatocellular and colorectal cancer cells."
05/01/2013 - "ITR-284 reduced the cell viability in human hepatocellular cancer cells (Hep G2, Hep 3B, SK-HEP-1 and J5) and colorectal cancer cells (HT 29, COLO 205, HCT 116 and SW 620). "
|4.||Hepatocellular Carcinoma (Hepatoma)
|5.||Body Weight (Weight, Body)
|1.||Tretinoin (Retinoic Acid)